An interesting manifestation of COVID-19 in children: case report and review on multisystem inflammatory syndrome in pediatric patients

Authors

  • Sharmila Pendyala Department of Paediatrics and Neonatology, Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana, India
  • Maryam Maqsood Department of Infectious Diseases, Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana, India
  • Vamsi Krishna Kaza Department of Medicine, Jawaharlal institute of postgraduate medical education and research, Puducherry, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20230747

Keywords:

MIS-C, COVID-19, PIMS-TS

Abstract

Multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 or PIMS-TS (pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection) has been presenting itself in children in connection to the SARS-CoV-2 infection. Along with a brief review of global data on MIS-C, we present two case reports of critically ill pediatric patients (aged 16 and 14 years), presenting with features of MIS-C from May 2020 to March 2021, to a tertiary-care hospital in Telangana, India. The patients with MIS-C were healthy prior to testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Clinical presentations were similar, with fever, abdominal pain, gastrointestinal complaints, or maculopapular rash. The diagnostic parameters revealed elevated levels of C-reactive protein, D-dimer, and NtProBNP. Other infectious aetiologies were ruled out. Both patients required ionotropic support, and intravenous immunoglobulin (IVIG), and were also given empiric antibiotics. Both were hemodynamically stable upon discharge. As knowledge of the various COVID-19 manifestations in children increases, reporting is essential to better-educating healthcare professionals in clarifying and streamlining the variety of symptoms connected to MIS-C and assessing the associated risk factors that predispose the pediatric population to develop severe disease.

 

References

MIS-C and COVID-19: Uncommon but serious inflammatory syndrome in kids and teens. 2022. Available at: Hopkinsmedicine.org website: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavirus/misc-and-covid19-rare-inflammatory-syndrome-in-kids-and-teens. Accessed on 22 January, 2023.

Pediatric COVID-19 international collaborative. WFPICCS-Pediatric Intensive and Critical Care website. Available at: https://wfpiccs.org/education/pediatric-covid-19-international-collaborative/. Accessed on 22 January, 2023.

Verdoni L. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8.

CDC. Multisystem Inflammatory Syndrome (MIS). 2023. Centers for Disease Control and Prevention website: https://www.cdc.gov/mis/index.html. Accessed on 22 January, 2023.

Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. Int J Environmental Res Pub Heal. 2021;18(5):2621.

Nikolopoulou GB, Maltezou HC. COVID-19 in Children: Where do we Stand? Arch Med Res. 2022;53(1):1-8.

Abdulamir A, Hafidh R. The possible immunological pathways for the variable immunopathogenesis of COVID-19 infections among healthy adults, elderly and children. Electron J Gen Med. 2020;17:em202.2020.

Shekerdemian LS, Mahmood NR, Wolfe KK. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174:868-73.

Abrams JY, Godfred-Cato SE, Oster ME. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2: a systemic review. J Pediatr. 2020;226:45-54.

Maltezou HC, Pavli A, Tsakris A. Post-COVID syndrome: An insight on its pathogenesis. Vaccines. 2021;9(5):497.

WHO. 2020. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Available at: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19. Accessed on 22 January, 2023.

Multisystem inflammatory syndrome in children (MIS-C). Available at: https://www.elsevier.com/__data/assets/pdf_file/0007/1029418/Multisystem-inflammatory-syndrome-in-children.pdf. Accessed on 22 January, 2023.

Weisberg SP, Connors T, Zhu Y, Baldwin M, Lin WH, Wontakal S et al. Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19. MedRxiv. 2020.

Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020;183(4):729-37.

Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Investigation. 2020;130(11):5967-75.

Schwartz M. MIS-C: post-infectious syndrome or persistent infection? Lancet Infect Dis. 2021;21(5):e116.

Bouslama B, Pierret C, Khelfaoui F, Bellanné-Chantelot C, Donadieu J et al. Post-COVID-19 severe neutropenia. Pediatric Blood and Cancer, Wiley. 2021;68(5).

Anderson JE, Campbell JA, Durowoju L, Greenberg SLM, Rice-Townsend SE, Gow KW et al. COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) presenting as appendicitis with shock. J Pediatr Surg Case Rep. 2021;71(101913):101913.

Kashyap H, Gupta V, Gupta A, Gupta T, Sharma S, Valjiyani S. Post-COVID syndrome (MIS-C) with refractory status epilepticus. Indian J Pediatr. 2021;88(7):721.

Vella LA, Rowley AH. Current insights into the pathophysiology of multisystem inflammatory syndrome in children. Curr Pediatr Rep. 2021;9(4):83-92.

Ouldali N. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health. 2020;4(9):662-8.

McCrindle BW. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927-99.

Godfred-Cato S. COVID-19-associated multisystem inflammatory syndrome in children - United States, March-July 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1074-80.

Carter MJ, Fish M, Jennings A, Doores KJ, Wellman P, Seow J, Shankar-Hari M. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nature Med. 2020;26(11):1701-7.

HAN archive-Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). (2021, September 21). Available at: https://emergency.cdc.gov/han/2020/han00432.asp?deliveryName=USCDC_511-DM28431. Accessed on 22 January, 2023.

Godfred-Cato S, Bryant B, Leung J. COVID-19-associated multisystem inflammatory syndrome in children-United States, March-July 2020. MMWR. Morbidity and mortality weekly report. 2020;69(32):1074-80.

Rowley AH. Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children. Nature Reviews Immunology. 2021;21(4):244-6.

Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004;364(9433):533-44.

Downloads

Published

2023-03-27

Issue

Vol. 10 No. 4 (2023): April 2023

Section

Case Reports